tiprankstipranks
Sienna Biopharmaceuticals (SNNAQ)
OTHER OTC:SNNAQ
US Market
SNNAQ
Sienna Biopharmaceuticals
RESEARCH TOOLSreports
Want to see SNNAQ full AI Analyst Report?

Sienna Biopharmaceuticals (SNNAQ) Income Statement

71 Followers

Sienna Biopharmaceuticals Income Statement

Last quarter (Q3 2019), Sienna Biopharmaceuticals's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Sienna Biopharmaceuticals's net income was $-3.97M. See Sienna Biopharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 18Dec 17
Total Revenue
$ 0.00$ 0.00
Gross Profit
$ -157.00K$ -120.00K
Operating Expenses
$ 76.50M$ 48.57M
Depreciation and Amortization
$ 157.00K$ 120.00K
EBITDA
$ -76.34M$ -48.45M
Operating Income
$ -76.50M$ -48.57M
Other Income/Expenses
$ 3.03M$ -2.26M
Pretax Income
$ -73.47M$ -50.84M
Net Income
$ -73.31M$ -50.55M
Per Share Metrics
Basic EPS
$ -3.59$ -5.19
Diluted EPS
$ -3.59$ -5.19
Weighted Average Shares Outstanding
 20.45M 9.73M
Weighted Average Shares Outstanding (Diluted)
 20.45M 9.73M
Currency in USD

Sienna Biopharmaceuticals Earnings and Revenue History